Literature DB >> 29413038

Atezolizumab and bladder cancer: facing a complex disease.

Carlo Cattrini1, Francesco Boccardo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29413038     DOI： 10.1016/S0140-6736(18)30095-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance.

Authors:  Yinjie Su; Weiping Yang; Ning Jiang; Juanyi Shi; Luping Chen; Guangzheng Zhong; Junming Bi; Wei Dong; Qiong Wang; Chunhui Wang; Tianxin Lin
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

Review 2.  The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma.

Authors:  Tucci Marco; Passarelli Anna; Todisco Annalisa; Mannavola Francesco; Stucci Luigia Stefania; D'Oronzo Stella; Rossini Michele; Taurisano Marco; Gesualdo Loreto; Silvestris Franco
Journal:  Ther Adv Med Oncol       Date:  2019-09-24       Impact factor: 8.168

3.  Medical Image Diagnostic Value of Computed Tomography for Bladder Tumors.

Authors:  Lin Li; Risu Na; Tao Mi; Hao Cheng; Lili Ma; Guojun Chen
Journal:  Comput Math Methods Med       Date:  2021-11-16       Impact factor: 2.238

4.  Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis.

Authors:  Wenlong Zhang; Xin He; Haoli Yin; Wenmin Cao; Tingsheng Lin; Wei Chen; Wenli Diao; Meng Ding; Hao Hu; Wenjing Mo; Qing Zhang; Hongqian Guo
Journal:  J Hematol Oncol       Date:  2022-07-14       Impact factor: 23.168

5.  Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway.

Authors:  Qixue Wang; Jinquan Cai; Chuan Fang; Chao Yang; Junhu Zhou; Yanli Tan; Yunfei Wang; Yansheng Li; Xiangqi Meng; Kai Zhao; Kaikai Yi; Sijing Zhang; Jianning Zhang; Chuanlu Jiang; Jing Zhang; Chunsheng Kang
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

6.  The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway.

Authors:  Jinan Guo; Zhixin Chen; Hongtao Jiang; Zhou Yu; Junming Peng; Jing Xie; ZaiShang Li; Weiqing Wu; Zhiqiang Cheng; Kefeng Xiao
Journal:  Cancer Cell Int       Date:  2019-11-26       Impact factor: 5.722

7.  Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling.

Authors:  Chaozhi Tang; Jiakang Ma; Xiuli Liu; Zhengchun Liu
Journal:  Stem Cell Res Ther       Date:  2020-10-28       Impact factor: 6.832
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.